Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Santoni-Rugiu

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 5, 2013
Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinomaBenedikte Jacobsen, Thomas Muley, Michael Meister, et al.
Frontiers in Endocrinology|September 23, 2021
Prevalence of Pathogenic Germline <i>DICER1</i> Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish CohortMays Altaraihi, Thomas van Overeem Hansen, Eric Santoni-Rugiu, et al.
Basic & Clinical Pharmacology & Toxicology|June 22, 2010
Safety pharmacology, toxicology and pharmacokinetic assessment of human Gc globulin (vitamin D binding protein)Tina Holberg Pihl, Charlotte Svaerke Jørgensen, Eric Santoni-Rugiu, et al.
Respiratory Research|July 17, 2010
Lipocalin 2 is protective against E. coli pneumoniaHong Wu, Eric Santoni-Rugiu, Elisabeth Ralfkiaer, et al.
Cancers|July 4, 2019
Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired ResistanceEric Santoni-Rugiu, Linea C Melchior, Edyta M Urbanska, et al.
Cells|October 23, 2021
Functional Proteomic Profiling of Triple-Negative Breast CancerIrina Gromova, Jaime A Espinoza, Morten Grauslund, et al.
Translational Lung Cancer Research|October 21, 2024
ALK-tyrosine kinase inhibitor intrinsic resistance due to <i>de novo</i> <i>MET</i>-amplification in metastatic <i>ALK</i>-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case reportEdyta M Urbanska, Morten Grauslund, Siv M S Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumorsHeidi Rye Hudlebusch, Eric Santoni-Rugiu, Ronald Simon, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 14, 2026
Deep Learning-Based Tumor Cell Classification in Lung Adenocarcinoma With a Case-by-Case Human-in-the-Loop ApproachMartin Stampe, Pia Klausen, Ida Skovgaard Christiansen, et al.
Acta Oncologica (Stockholm, Sweden)|May 21, 2026
Survival and relapse of Danish patients with thymic epithelial tumorsTine Østergaard, Caroline Van Alstine Bjerke, Eric Santoni-Rugiu, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 5, 2013
Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinomaBenedikte Jacobsen, Thomas Muley, Michael Meister, et al.
Frontiers in Endocrinology|September 23, 2021
Prevalence of Pathogenic Germline <i>DICER1</i> Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish CohortMays Altaraihi, Thomas van Overeem Hansen, Eric Santoni-Rugiu, et al.
Basic & Clinical Pharmacology & Toxicology|June 22, 2010
Safety pharmacology, toxicology and pharmacokinetic assessment of human Gc globulin (vitamin D binding protein)Tina Holberg Pihl, Charlotte Svaerke Jørgensen, Eric Santoni-Rugiu, et al.
Respiratory Research|July 17, 2010
Lipocalin 2 is protective against E. coli pneumoniaHong Wu, Eric Santoni-Rugiu, Elisabeth Ralfkiaer, et al.
Cancers|July 4, 2019
Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired ResistanceEric Santoni-Rugiu, Linea C Melchior, Edyta M Urbanska, et al.
Cells|October 23, 2021
Functional Proteomic Profiling of Triple-Negative Breast CancerIrina Gromova, Jaime A Espinoza, Morten Grauslund, et al.
Translational Lung Cancer Research|October 21, 2024
ALK-tyrosine kinase inhibitor intrinsic resistance due to <i>de novo</i> <i>MET</i>-amplification in metastatic <i>ALK</i>-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case reportEdyta M Urbanska, Morten Grauslund, Siv M S Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumorsHeidi Rye Hudlebusch, Eric Santoni-Rugiu, Ronald Simon, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 14, 2026
Deep Learning-Based Tumor Cell Classification in Lung Adenocarcinoma With a Case-by-Case Human-in-the-Loop ApproachMartin Stampe, Pia Klausen, Ida Skovgaard Christiansen, et al.
Acta Oncologica (Stockholm, Sweden)|May 21, 2026
Survival and relapse of Danish patients with thymic epithelial tumorsTine Østergaard, Caroline Van Alstine Bjerke, Eric Santoni-Rugiu, et al.
Pageof 10